Gilead Sciences Inc.

01/21/2022 | Press release | Distributed by Public on 01/21/2022 17:26

FDA Approves Veklury® (Remdesivir) for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression